TRI LOCUM PARTNERS LP – Eli Lilly and Company Transaction History
TRI LOCUM PARTNERS LP portfolio value:
$34.00M
portfolio value
TRI LOCUM PARTNERS LP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +50.96% | 35.50K shares | 11.41M | $323.35 | 105.17K |
| Q2 2022 | share | Increase | +67.43% | 28.05K shares | 10.67M | $324.23 | 69.66K |
| Q1 2022 | share | Decrease | -47.01% | -36.91K shares | -9.77M | $286.37 | 41.61K |
| Q4 2021 | share | Increase | 0.00% | 78.52K shares | 21.69M | $277.25 | 78.52K |
| Q2 2021 | share | Decrease | -100.00% | -48.29K shares | -9.02M | $228.04 | 0 |
| Q1 2021 | share | Decrease | -13.01% | -7.22K shares | -351K | $184.81 | 48.29K |
| Q4 2020 | share | Increase | 0.00% | 55.52K shares | 9.37M | $166.32 | 55.52K |